ROWAN: An Open-Label, Prospective, Multi-Center, Randomized Clinical Trial ToEvaluate The Efficacy and Safety Of TheraSphere followed by Durvalumab (Imfinzi?) WithTremelimumab, Versus TheraSphere Alone For Hepatocellular Carcinoma (HCC)

Project: Research project


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science